Assessing radiation oncology research needs in India: Results of a physician survey.


Journal

Indian journal of cancer
ISSN: 1998-4774
Titre abrégé: Indian J Cancer
Pays: India
ID NLM: 0112040

Informations de publication

Date de publication:
Historique:
pubmed: 10 8 2020
medline: 30 6 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

In India, where the annual incidence of cancer is projected to reach 1.7 million by 2020, the need for clinical research to establish the most effective, resource-guided, and evidence-based care is paramount. In this study, we sought to better understand the research training needs of radiation oncologists in India. A 12 item questionnaire was developed to assess research training needs and was distributed at the research methods course jointly organized by Indian College of Radiation Oncology, the American Brachytherapy Society, and Education Committee of the American Society of Therapeutic Radiation Oncology during the Indian Cancer Congress, 2017. Of 100 participants who received the questionnaire, 63% responded. Ninety percent (56/63) were Radiation Oncologists. Forty-two percent (26/63) of respondents had previously conducted research. A longer length of practice (>10 years) was significantly associated with conducting research (odds ratio (OR) 6.99, P = 0.031) and having formal research training trended toward significance (OR 3.03, P = 0.058). The most common reason for not conducting research was "lack of training" (41%, 14/34). The most common types of research conducted were Audits and Retrospective studies (62%, 16/26), followed by a Phase I/II/III Trial (46%, 10/26). Having formal research training was a significant factor associated with writing a protocol (OR 5.53, P = 0.016). Limited training in research methods (54%, 13/24) and lack of mentorship (42%, 10/24) were cited as reasons for not developing a protocol. Ninety-seven percent (57/59) of respondents were interested in a didactic session on research, specifically focusing on biostatistics. With research training and mentorship, there is a greater likelihood that concepts and written protocols will translate into successfully completed studies in radiation therapy.

Sections du résumé

BACKGROUND BACKGROUND
In India, where the annual incidence of cancer is projected to reach 1.7 million by 2020, the need for clinical research to establish the most effective, resource-guided, and evidence-based care is paramount. In this study, we sought to better understand the research training needs of radiation oncologists in India.
METHODS METHODS
A 12 item questionnaire was developed to assess research training needs and was distributed at the research methods course jointly organized by Indian College of Radiation Oncology, the American Brachytherapy Society, and Education Committee of the American Society of Therapeutic Radiation Oncology during the Indian Cancer Congress, 2017.
RESULTS RESULTS
Of 100 participants who received the questionnaire, 63% responded. Ninety percent (56/63) were Radiation Oncologists. Forty-two percent (26/63) of respondents had previously conducted research. A longer length of practice (>10 years) was significantly associated with conducting research (odds ratio (OR) 6.99, P = 0.031) and having formal research training trended toward significance (OR 3.03, P = 0.058). The most common reason for not conducting research was "lack of training" (41%, 14/34). The most common types of research conducted were Audits and Retrospective studies (62%, 16/26), followed by a Phase I/II/III Trial (46%, 10/26). Having formal research training was a significant factor associated with writing a protocol (OR 5.53, P = 0.016). Limited training in research methods (54%, 13/24) and lack of mentorship (42%, 10/24) were cited as reasons for not developing a protocol. Ninety-seven percent (57/59) of respondents were interested in a didactic session on research, specifically focusing on biostatistics.
CONCLUSIONS CONCLUSIONS
With research training and mentorship, there is a greater likelihood that concepts and written protocols will translate into successfully completed studies in radiation therapy.

Identifiants

pubmed: 32769296
pii: 290281
doi: 10.4103/ijc.IJC_518_19
pmc: PMC7990497
mid: NIHMS1672284
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

457-462

Subventions

Organisme : NCI NIH HHS
ID : K08 CA230170
Pays : United States

Déclaration de conflit d'intérêts

None

Références

Clin Oncol (R Coll Radiol). 2014 Mar;26(3):162-73
pubmed: 24447718
JAMA. 2006 Sep 6;296(9):1103-15
pubmed: 16954490
Semin Radiat Oncol. 2017 Apr;27(2):158-163
pubmed: 28325242
Am Soc Clin Oncol Educ Book. 2013;:411-3
pubmed: 23714562
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):767-778
pubmed: 29976487
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):957-60
pubmed: 26581132
Lancet Oncol. 2014 May;15(6):e223-33
pubmed: 24731888

Auteurs

Rohini Kishor Bhatia (RK)

University of Rochester School of Medicine and Dentistry, Rochester, USA.

Supriya Sastri Chopra (S)

Tata Memorial Centre, Mumbai, India.

Vijay Anand Reddy Palkonda (VAR)

Apollo Cancer Hospital, Navi Mumbai, India.

G V Giri (GV)

Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.

Surendranath Senapati (S)

Acharya Harihara Regional Cancer Centre, Odisha, India.

Ramesh S Bilimagga (RS)

Healthcare Global Enterprises Ltd., Bangalore, India.

Manjeet Chadha (M)

Icahn School of Medicine at Mount Sinai, New York, USA.

Akila N Viswanathan (AN)

Johns Hopkins Hospital, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.

Surbhi Grover (S)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH